The post USD/MXN extends slide after 50-DMA rejection – Société Générale appeared on BitcoinEthereumNews.com. USD/MXN has continued to fall after failing to holdThe post USD/MXN extends slide after 50-DMA rejection – Société Générale appeared on BitcoinEthereumNews.com. USD/MXN has continued to fall after failing to hold

USD/MXN extends slide after 50-DMA rejection – Société Générale

USD/MXN has continued to fall after failing to hold above the 50-day moving average, with the pair testing support near 17.85–17.80. While momentum indicators hint at potential stabilization, a break below current levels could open the door toward the July 2024 lows around 17.60, Société Générale’s FX analysts note.

Peso strengthens as pair nears key support

“USD/MXN has extended its decline after failing to establish above the 50-DMA (currently near 18.22). The pair has tested interim projections at 17.85/17.80. While the daily MACD continues to show positive divergence, clear signals of reversal are not yet visible in price action.”

“If a short-term bounce occurs, the moving average around 18.22 is likely to act as resistance. Failure to overcome this may lead to continuation in down move. The next objective could be located at the July 2024 lows near 17.60.”

Source: https://www.fxstreet.com/news/usd-mxn-extends-slide-after-50-dma-rejection-societe-generale-202601080923

Market Opportunity
NEAR Logo
NEAR Price(NEAR)
$1,7
$1,7$1,7
-%0,81
USD
NEAR (NEAR) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.